| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC12A6 TRPV1 ABCA1 TPCN2 TRPM7 SLC31A2 ABCA12 ATP13A1 SLC6A19 SLC35C2 TIMM23 ABCB6 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 SLC6A9 ABCG1 CACNG7 CLCN3 SLC12A4 KCND1 SLC22A14 ANO6 GLRA1 SLC22A3 PKD1 ABCC12 SLC22A20P CNGA3 TMEM63A | 4.59e-14 | 1180 | 127 | 34 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SLC12A6 TRPV1 ABCA1 TPCN2 TRPM7 SLC31A2 ABCA12 ATP13A1 SLC6A19 SLC35C2 TIMM23 ABCB6 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 SLC6A9 ABCG1 CACNG7 CLCN3 SLC12A4 KCND1 SLC22A14 ANO6 GLRA1 SLC22A3 PKD1 ABCC12 SLC22A20P CNGA3 TMEM63A | 5.71e-13 | 1289 | 127 | 34 | GO:0005215 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC12A6 TRPV1 TPCN2 TRPM7 SLC31A2 ATP13A1 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 SLC12A4 KCND1 SLC22A3 PKD1 CNGA3 | 1.49e-11 | 465 | 127 | 20 | GO:0046873 |
| GeneOntologyMolecularFunction | calcium channel activity | TRPV1 TPCN2 TRPM7 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 CACNG7 PKD1 CNGA3 | 3.60e-11 | 129 | 127 | 12 | GO:0005262 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC12A6 TRPV1 TPCN2 TRPM7 SLC31A2 ATP13A1 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 SLC12A4 KCND1 ANO6 GLRA1 SLC22A3 PKD1 CNGA3 TMEM63A | 6.81e-11 | 758 | 127 | 24 | GO:0015318 |
| GeneOntologyMolecularFunction | channel activity | SLC12A6 TRPV1 TPCN2 TRPM7 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 CACNG7 CLCN3 SLC12A4 KCND1 ANO6 GLRA1 PKD1 CNGA3 TMEM63A | 1.30e-10 | 525 | 127 | 20 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | SLC12A6 TRPV1 TPCN2 TRPM7 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 CACNG7 CLCN3 SLC12A4 KCND1 ANO6 GLRA1 PKD1 CNGA3 TMEM63A | 1.34e-10 | 526 | 127 | 20 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC12A6 TRPV1 TPCN2 TRPM7 SLC31A2 ATP13A1 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 SLC12A4 KCND1 ANO6 GLRA1 SLC22A3 PKD1 CNGA3 TMEM63A | 1.71e-10 | 793 | 127 | 24 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC12A6 TRPV1 TPCN2 TRPM7 SLC31A2 ATP13A1 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 SLC12A4 KCND1 ANO6 SLC22A3 PKD1 CNGA3 TMEM63A | 2.01e-10 | 664 | 127 | 22 | GO:0008324 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | TRPV1 TPCN2 TRPM7 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 CACNG7 PKD1 CNGA3 | 2.29e-10 | 151 | 127 | 12 | GO:0015085 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC12A6 TRPV1 TPCN2 TRPM7 SLC31A2 ATP13A1 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 SLC12A4 KCND1 SLC22A3 PKD1 CNGA3 TMEM63A | 4.48e-10 | 627 | 127 | 21 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | TRPV1 TPCN2 TRPM7 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 CACNG7 KCND1 ANO6 PKD1 CNGA3 TMEM63A | 5.90e-10 | 343 | 127 | 16 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | TRPV1 TPCN2 TRPM7 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 CACNG7 CLCN3 KCND1 ANO6 GLRA1 PKD1 CNGA3 TMEM63A | 7.51e-10 | 459 | 127 | 18 | GO:0005216 |
| GeneOntologyMolecularFunction | gated channel activity | TRPV1 TPCN2 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 CACNG7 CLCN3 KCND1 ANO6 GLRA1 CNGA3 TMEM63A | 3.53e-09 | 334 | 127 | 15 | GO:0022836 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.55e-08 | 46 | 127 | 7 | GO:0005245 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 5.65e-08 | 33 | 127 | 6 | GO:0005217 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 7.71e-08 | 18 | 127 | 5 | GO:0015278 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | TRPV1 TPCN2 CACHD1 RYR1 CACNG3 CACNG2 CACNG7 CLCN3 KCND1 ANO6 | 2.57e-07 | 182 | 127 | 10 | GO:0005244 |
| GeneOntologyMolecularFunction | voltage-gated channel activity | TRPV1 TPCN2 CACHD1 RYR1 CACNG3 CACNG2 CACNG7 CLCN3 KCND1 ANO6 | 2.85e-07 | 184 | 127 | 10 | GO:0022832 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 6.57e-07 | 49 | 127 | 6 | GO:0140359 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.00e-06 | 4 | 127 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.43e-06 | 31 | 127 | 5 | GO:0099604 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC12A6 ABCA1 ABCA12 ATP13A1 SLC6A19 SLC35C2 ABCB6 SLC6A4 SLC6A9 ABCG1 CLCN3 SLC12A4 SLC22A3 ABCC12 | 2.15e-06 | 477 | 127 | 14 | GO:0022804 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 3.17e-06 | 140 | 127 | 8 | GO:0099094 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 4.06e-06 | 193 | 127 | 9 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.80e-06 | 197 | 127 | 9 | GO:0022834 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 4.96e-06 | 6 | 127 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 5.85e-06 | 152 | 127 | 8 | GO:0022843 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 1.26e-05 | 23 | 127 | 4 | GO:0015377 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.53e-05 | 125 | 127 | 7 | GO:0015108 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 2.09e-05 | 26 | 127 | 4 | GO:0015296 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 5.15e-05 | 151 | 127 | 7 | GO:0008509 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 6.97e-05 | 109 | 127 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.13e-04 | 171 | 127 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 3.09e-04 | 51 | 127 | 4 | GO:0140303 | |
| GeneOntologyMolecularFunction | symporter activity | 3.98e-04 | 150 | 127 | 6 | GO:0015293 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DNAH3 MYH7 ABCA1 ERCC2 ABCA12 ATP13A1 ABCB6 ABCG1 ABCC12 DNAH8 | 5.23e-04 | 441 | 127 | 10 | GO:0016887 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 6.20e-04 | 296 | 127 | 8 | GO:0015291 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 7.33e-04 | 28 | 127 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | fatty acid elongase activity | 8.25e-04 | 7 | 127 | 2 | GO:0009922 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 8.32e-04 | 238 | 127 | 7 | GO:0016747 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 9.79e-04 | 178 | 127 | 6 | GO:0015399 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 9.85e-04 | 119 | 127 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 1.10e-03 | 8 | 127 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 1.40e-03 | 9 | 127 | 2 | GO:0034040 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 1.40e-03 | 9 | 127 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 2.13e-03 | 11 | 127 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | TRPV1 ABCA1 ADGRG3 GPR173 LMBR1 OR5A1 GRM1 OR2L13 LPAR1 TAS2R13 OR6B3 PTPRO GLRA1 PKD1 CCR8 OR10G8 OR6B2 TMEM63A | 2.28e-03 | 1353 | 127 | 18 | GO:0004888 |
| GeneOntologyMolecularFunction | protein transporter activity | 2.41e-03 | 42 | 127 | 3 | GO:0140318 | |
| GeneOntologyMolecularFunction | monoamine transmembrane transporter activity | 2.54e-03 | 12 | 127 | 2 | GO:0008504 | |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 2.54e-03 | 12 | 127 | 2 | GO:0019534 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 2.54e-03 | 12 | 127 | 2 | GO:0008519 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.56e-03 | 230 | 127 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | floppase activity | 4.54e-03 | 16 | 127 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.77e-03 | 171 | 127 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 5.13e-03 | 17 | 127 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 5.13e-03 | 17 | 127 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | prenyltransferase activity | 5.74e-03 | 18 | 127 | 2 | GO:0004659 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 5.74e-03 | 18 | 127 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNAH3 MYH7 ABCA1 ERCC2 ABCA12 ATP13A1 ABCB6 ABCG1 ABCC12 DNAH8 | 5.88e-03 | 614 | 127 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 6.39e-03 | 19 | 127 | 2 | GO:0015373 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC12A6 TRPV1 TPCN2 TRPM7 SLC31A2 ATP13A1 SLC6A19 ABCB6 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 SLC12A4 KCND1 ANO6 PKD1 CNGA3 TMEM63A | 2.80e-09 | 942 | 127 | 24 | GO:0098655 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC12A6 TRPV1 TPCN2 TRPM7 SLC31A2 ATP13A1 SLC6A19 ABCB6 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 SLC12A4 KCND1 ANO6 PKD1 CNGA3 | 9.35e-09 | 922 | 127 | 23 | GO:0098662 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC12A6 TRPV1 TPCN2 TRPM7 SLC31A2 ATP13A1 SLC6A19 ABCB6 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 SLC12A4 KCND1 ANO6 GLRA1 PKD1 CNGA3 | 1.24e-08 | 1017 | 127 | 24 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC12A6 TRPV1 TPCN2 TRPM7 SLC31A2 ATP13A1 SLC6A19 ABCB6 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 SLC12A4 KCND1 ANO6 GLRA1 PKD1 CNGA3 TMEM63A | 1.61e-08 | 1115 | 127 | 25 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC12A6 TRPV1 TPCN2 TRPM7 SLC31A2 ATP13A1 SLC6A19 ABCB6 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 SLC12A4 KCND1 ANO6 GLRA1 SLC22A3 PKD1 SLC22A20P CNGA3 TMEM63A | 6.07e-08 | 1374 | 127 | 27 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC12A6 TRPV1 TPCN2 TRPM7 SLC31A2 ATP13A1 SLC6A19 ABCB6 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 SLC12A4 KCND1 ANO6 PKD1 CNGA3 TMEM63A | 1.40e-07 | 1157 | 127 | 24 | GO:0006812 |
| GeneOntologyBiologicalProcess | metal ion transport | SLC12A6 TRPV1 TPCN2 TRPM7 SLC31A2 ATP13A1 SLC6A19 ABCB6 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 SLC12A4 KCND1 ANO6 PKD1 CNGA3 | 1.86e-07 | 1000 | 127 | 22 | GO:0030001 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | TRPV1 TPCN2 TRPM7 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 CACNG7 ANO6 PKD1 CNGA3 | 9.31e-07 | 392 | 127 | 13 | GO:0070588 |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 4.53e-06 | 40 | 127 | 5 | GO:0071312 | |
| GeneOntologyBiologicalProcess | membrane lipid metabolic process | 1.25e-05 | 229 | 127 | 9 | GO:0006643 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport, postsynaptic endosome to lysosome | 1.25e-05 | 8 | 127 | 3 | GO:0098943 | |
| GeneOntologyBiologicalProcess | sphingolipid metabolic process | 1.36e-05 | 176 | 127 | 8 | GO:0006665 | |
| GeneOntologyBiologicalProcess | calcium ion transport | TRPV1 TPCN2 TRPM7 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 CACNG7 ANO6 PKD1 CNGA3 | 1.59e-05 | 509 | 127 | 13 | GO:0006816 |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 3.63e-05 | 11 | 127 | 3 | GO:0071313 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | SPTSSA HACD3 CH25H ELOVL1 GPAT3 COQ2 CERS5 ABCG1 BMX PLA2G4C SERINC1 FDFT1 SERINC4 FAR1 ELOVL6 PIGM | 4.02e-05 | 813 | 127 | 16 | GO:0008610 |
| GeneOntologyBiologicalProcess | neurotransmitter receptor diffusion trapping | 6.23e-05 | 13 | 127 | 3 | GO:0099628 | |
| GeneOntologyBiologicalProcess | very long-chain fatty acid biosynthetic process | 6.23e-05 | 13 | 127 | 3 | GO:0042761 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor diffusion trapping | 6.23e-05 | 13 | 127 | 3 | GO:0098970 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 7.66e-05 | 166 | 127 | 7 | GO:0014074 | |
| GeneOntologyBiologicalProcess | receptor diffusion trapping | 7.90e-05 | 14 | 127 | 3 | GO:0098953 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 7.90e-05 | 14 | 127 | 3 | GO:0071415 | |
| GeneOntologyBiologicalProcess | fatty acid elongation | 9.83e-05 | 15 | 127 | 3 | GO:0030497 | |
| GeneOntologyBiologicalProcess | phospholipid efflux | 9.83e-05 | 15 | 127 | 3 | GO:0033700 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | SLC12A6 TPCN2 TRPM7 SLC31A2 ABCA12 ATP13A1 ABCB6 GRM1 ADCY8 RYR1 RYR2 RYR3 ABCG1 CLCN3 SLC12A4 ANO6 CLN5 | 1.09e-04 | 981 | 127 | 17 | GO:0019725 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | SLC12A6 TPCN2 TRPM7 SLC31A2 ATP13A1 ABCB6 GRM1 ADCY8 RYR1 RYR2 RYR3 CLCN3 SLC12A4 CLN5 | 1.15e-04 | 705 | 127 | 14 | GO:0055080 |
| GeneOntologyBiologicalProcess | response to alkaloid | 1.25e-04 | 125 | 127 | 6 | GO:0043279 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport | 1.28e-04 | 42 | 127 | 4 | GO:0099637 | |
| GeneOntologyBiologicalProcess | cell volume homeostasis | 1.28e-04 | 42 | 127 | 4 | GO:0006884 | |
| GeneOntologyBiologicalProcess | protein localization to postsynapse | 1.36e-04 | 80 | 127 | 5 | GO:0062237 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | SLC12A6 TPCN2 TRPM7 SLC31A2 ATP13A1 ABCB6 GRM1 ADCY8 RYR1 RYR2 RYR3 CLCN3 SLC12A4 CLN5 | 1.37e-04 | 717 | 127 | 14 | GO:0050801 |
| GeneOntologyBiologicalProcess | ammonium import across plasma membrane | 2.24e-04 | 4 | 127 | 2 | GO:0140157 | |
| GeneOntologyBiologicalProcess | cellular response to high density lipoprotein particle stimulus | 2.24e-04 | 4 | 127 | 2 | GO:0071403 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor localization to postsynaptic specialization membrane | 2.34e-04 | 49 | 127 | 4 | GO:0099645 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic specialization membrane | 2.34e-04 | 49 | 127 | 4 | GO:0099633 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 2.46e-04 | 266 | 127 | 8 | GO:0019722 | |
| GeneOntologyBiologicalProcess | response to organophosphorus | 2.50e-04 | 142 | 127 | 6 | GO:0046683 | |
| GeneOntologyBiologicalProcess | cellular response to ATP | 2.80e-04 | 21 | 127 | 3 | GO:0071318 | |
| GeneOntologyBiologicalProcess | response to caffeine | 2.80e-04 | 21 | 127 | 3 | GO:0031000 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | SLC12A6 TPCN2 TRPM7 SLC31A2 ABCA12 ATP13A1 ABCB6 GRM1 ADCY8 RYR1 RYR2 RYR3 ABCG1 CLCN3 CLN5 | 2.87e-04 | 866 | 127 | 15 | GO:0055082 |
| GeneOntologyBiologicalProcess | intracellular lipid transport | 3.18e-04 | 53 | 127 | 4 | GO:0032365 | |
| GeneOntologyBiologicalProcess | import into cell | SLC12A6 TRPV1 ABCA1 TPCN2 GRM1 LPAR1 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 SLC12A4 ANO6 SLC22A3 MKLN1 CNGA3 | 3.19e-04 | 1074 | 127 | 17 | GO:0098657 |
| GeneOntologyBiologicalProcess | synaptic transmission, glycinergic | 3.72e-04 | 5 | 127 | 2 | GO:0060012 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 3.93e-04 | 56 | 127 | 4 | GO:0099601 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | TPCN2 TRPM7 SLC31A2 ATP13A1 ABCB6 GRM1 ADCY8 RYR1 RYR2 RYR3 CLCN3 CLN5 | 3.98e-04 | 611 | 127 | 12 | GO:0030003 |
| GeneOntologyBiologicalProcess | receptor localization to synapse | 4.04e-04 | 101 | 127 | 5 | GO:0097120 | |
| GeneOntologyBiologicalProcess | negative regulation of nervous system process | 4.20e-04 | 24 | 127 | 3 | GO:0031645 | |
| GeneOntologyBiologicalProcess | membrane lipid biosynthetic process | 4.28e-04 | 157 | 127 | 6 | GO:0046467 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor internalization | 4.50e-04 | 58 | 127 | 4 | GO:0099590 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | SLC12A6 TPCN2 TRPM7 SLC31A2 ATP13A1 ABCB6 GRM1 ADCY8 RYR1 RYR2 RYR3 SLC12A4 | 4.66e-04 | 622 | 127 | 12 | GO:0098771 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | TPCN2 TRPM7 SLC31A2 ATP13A1 ABCB6 GRM1 ADCY8 RYR1 RYR2 RYR3 CLCN3 CLN5 | 4.66e-04 | 622 | 127 | 12 | GO:0006873 |
| GeneOntologyBiologicalProcess | response to magnesium ion | 4.75e-04 | 25 | 127 | 3 | GO:0032026 | |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 4.75e-04 | 25 | 127 | 3 | GO:2000311 | |
| GeneOntologyBiologicalProcess | oligodendrocyte development | 4.80e-04 | 59 | 127 | 4 | GO:0014003 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | 4.81e-04 | 224 | 127 | 7 | GO:0007204 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 4.89e-04 | 161 | 127 | 6 | GO:0051592 | |
| GeneOntologyBiologicalProcess | lipid translocation | 5.12e-04 | 60 | 127 | 4 | GO:0034204 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 5.40e-04 | 164 | 127 | 6 | GO:0099072 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol efflux | 5.98e-04 | 27 | 127 | 3 | GO:0010875 | |
| GeneOntologyBiologicalProcess | long-chain fatty-acyl-CoA metabolic process | 5.98e-04 | 27 | 127 | 3 | GO:0035336 | |
| GeneOntologyBiologicalProcess | regulation of system process | MYH7 TRPV1 CTSC GRM1 RYR1 RYR2 DOCK5 CACNG7 PTPRO GLRA1 CNTNAP2 FGB MYMK | 6.04e-04 | 734 | 127 | 13 | GO:0044057 |
| GeneOntologyBiologicalProcess | chemical homeostasis | SLC12A6 ABCA1 TPCN2 TRPM7 SLC31A2 ABCA12 ATP13A1 ABCB6 GRM1 ADCY8 RYR1 RYR2 RYR3 ABCG1 CLCN3 SLC12A4 CLN5 TMEM63A | 6.44e-04 | 1249 | 127 | 18 | GO:0048878 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 6.48e-04 | 112 | 127 | 5 | GO:1902476 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 6.48e-04 | 112 | 127 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | ceramide metabolic process | 6.75e-04 | 113 | 127 | 5 | GO:0006672 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 6.75e-04 | 113 | 127 | 5 | GO:0051262 | |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 6.94e-04 | 65 | 127 | 4 | GO:0097035 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 7.31e-04 | 115 | 127 | 5 | GO:0035418 | |
| GeneOntologyBiologicalProcess | fatty acid elongation, polyunsaturated fatty acid | 7.74e-04 | 7 | 127 | 2 | GO:0034626 | |
| GeneOntologyBiologicalProcess | fatty acid elongation, monounsaturated fatty acid | 7.74e-04 | 7 | 127 | 2 | GO:0034625 | |
| GeneOntologyBiologicalProcess | fatty acid elongation, unsaturated fatty acid | 7.74e-04 | 7 | 127 | 2 | GO:0019368 | |
| GeneOntologyBiologicalProcess | sphingolipid biosynthetic process | 7.90e-04 | 117 | 127 | 5 | GO:0030148 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 9.92e-04 | 32 | 127 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | phospholipid metabolic process | 9.99e-04 | 410 | 127 | 9 | GO:0006644 | |
| GeneOntologyBiologicalProcess | negative regulation of cell volume | 1.03e-03 | 8 | 127 | 2 | GO:0045794 | |
| GeneOntologyBiologicalProcess | fatty acid elongation, saturated fatty acid | 1.03e-03 | 8 | 127 | 2 | GO:0019367 | |
| GeneOntologyBiologicalProcess | response to metal ion | 1.09e-03 | 415 | 127 | 9 | GO:0010038 | |
| GeneOntologyBiologicalProcess | chloride transport | 1.18e-03 | 128 | 127 | 5 | GO:0006821 | |
| GeneOntologyBiologicalProcess | response to nutrient | 1.23e-03 | 192 | 127 | 6 | GO:0007584 | |
| GeneOntologyBiologicalProcess | viral life cycle | 1.23e-03 | 340 | 127 | 8 | GO:0019058 | |
| GeneOntologyBiologicalProcess | very long-chain fatty acid metabolic process | 1.29e-03 | 35 | 127 | 3 | GO:0000038 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic membrane | 1.31e-03 | 77 | 127 | 4 | GO:1903539 | |
| GeneOntologyBiologicalProcess | negative regulation of transmission of nerve impulse | 1.32e-03 | 9 | 127 | 2 | GO:0051970 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 1.36e-03 | 132 | 127 | 5 | GO:0035249 | |
| GeneOntologyBiologicalProcess | phospholipid biosynthetic process | 1.37e-03 | 268 | 127 | 7 | GO:0008654 | |
| GeneOntologyBiologicalProcess | intracellular cholesterol transport | 1.40e-03 | 36 | 127 | 3 | GO:0032367 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 1.45e-03 | 134 | 127 | 5 | GO:0098661 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.52e-03 | 37 | 127 | 3 | GO:0014808 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | 1.59e-03 | 354 | 127 | 8 | GO:0071695 | |
| GeneOntologyBiologicalProcess | developmental maturation | 1.60e-03 | 439 | 127 | 9 | GO:0021700 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol by endoplasmic reticulum | 1.77e-03 | 39 | 127 | 3 | GO:1903514 | |
| GeneOntologyBiologicalProcess | intracellular sterol transport | 1.77e-03 | 39 | 127 | 3 | GO:0032366 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | SLC12A6 TRPV1 GRM1 ADCY8 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 SLC12A4 GLRA1 CNTNAP2 TENT2 | 1.80e-03 | 931 | 127 | 14 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | SLC12A6 TRPV1 GRM1 ADCY8 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 SLC12A4 GLRA1 CNTNAP2 TENT2 | 1.80e-03 | 931 | 127 | 14 | GO:0007268 |
| GeneOntologyBiologicalProcess | endosome to lysosome transport | 1.81e-03 | 84 | 127 | 4 | GO:0008333 | |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 1.81e-03 | 84 | 127 | 4 | GO:0051480 | |
| GeneOntologyBiologicalProcess | peptide metabolic process | 1.81e-03 | 84 | 127 | 4 | GO:0006518 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.84e-03 | 208 | 127 | 6 | GO:0035725 | |
| GeneOntologyBiologicalProcess | response to ATP | 1.91e-03 | 40 | 127 | 3 | GO:0033198 | |
| GeneOntologyBiologicalProcess | positive regulation of sterol transport | 1.91e-03 | 40 | 127 | 3 | GO:0032373 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol transport | 1.91e-03 | 40 | 127 | 3 | GO:0032376 | |
| GeneOntologyCellularComponent | calcium channel complex | 6.81e-10 | 73 | 129 | 9 | GO:0034704 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | ABCA1 LMF1 CLGN SPTSSA HACD3 ATP13A1 CH25H SPPL3 ELOVL1 GPAT3 WDR81 ABCB6 OR2L13 RYR1 RYR2 RYR3 STT3A CERS5 YIF1A ABCG1 PLA2G4C SERINC1 FDFT1 SLC22A3 TMEM147 ABCC12 ELOVL6 PIGM | 7.65e-09 | 1327 | 129 | 28 | GO:0042175 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | TPCN2 CATSPERD CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 CACNG7 KCND1 ANO6 GLRA1 PKD1 CNTNAP2 CNGA3 | 1.26e-08 | 378 | 129 | 15 | GO:0034702 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | ABCA1 LMF1 CLGN SPTSSA HACD3 ATP13A1 CH25H SPPL3 ELOVL1 GPAT3 WDR81 ABCB6 OR2L13 RYR1 RYR2 RYR3 STT3A CERS5 YIF1A ABCG1 PLA2G4C SERINC1 FDFT1 TMEM147 ABCC12 ELOVL6 PIGM | 1.86e-08 | 1293 | 129 | 27 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | ABCA1 LMF1 CLGN SPTSSA HACD3 ATP13A1 CH25H SPPL3 ELOVL1 GPAT3 WDR81 ABCB6 OR2L13 RYR1 RYR2 RYR3 STT3A CERS5 YIF1A ABCG1 PLA2G4C SERINC1 FDFT1 TMEM147 ABCC12 ELOVL6 PIGM | 2.05e-08 | 1299 | 129 | 27 | GO:0098827 |
| GeneOntologyCellularComponent | cation channel complex | CATSPERD CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 CACNG7 KCND1 PKD1 CNTNAP2 CNGA3 | 2.53e-08 | 235 | 129 | 12 | GO:0034703 |
| GeneOntologyCellularComponent | transmembrane transporter complex | TPCN2 CATSPERD ABCB6 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 CACNG7 KCND1 ANO6 GLRA1 PKD1 CNTNAP2 CNGA3 | 1.48e-07 | 523 | 129 | 16 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | TPCN2 CATSPERD ABCB6 CACHD1 RYR1 RYR2 RYR3 CACNG3 CACNG2 CACNG7 KCND1 ANO6 GLRA1 PKD1 CNTNAP2 CNGA3 | 2.92e-07 | 550 | 129 | 16 | GO:1990351 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.76e-07 | 46 | 129 | 6 | GO:0005891 | |
| GeneOntologyCellularComponent | synaptic membrane | TRPV1 GRM1 LPAR1 ADCY8 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 KCND1 PTPRO ANO6 GLRA1 CNTNAP2 MKLN1 | 6.32e-07 | 583 | 129 | 16 | GO:0097060 |
| GeneOntologyCellularComponent | postsynaptic membrane | TRPV1 GRM1 LPAR1 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 KCND1 PTPRO GLRA1 MKLN1 | 1.38e-06 | 405 | 129 | 13 | GO:0045211 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | ADGRG3 TPCN2 ANPEP TRPM7 SLC31A2 ABCA12 SPPL3 WDR81 ABCB6 ADCY8 CACNG3 CACNG2 SLC6A4 SLC6A9 CLCN3 ANO6 SNX25 PKD1 MKLN1 TMEM63A | 1.48e-04 | 1307 | 129 | 20 | GO:0030659 |
| GeneOntologyCellularComponent | postsynapse | TRPV1 KALRN GRM1 LPAR1 ADCY8 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 KCND1 PTPRO GLRA1 CNTNAP2 MKLN1 TENT2 | 1.76e-04 | 1018 | 129 | 17 | GO:0098794 |
| GeneOntologyCellularComponent | vesicle membrane | ADGRG3 TPCN2 ANPEP TRPM7 SLC31A2 ABCA12 SPPL3 WDR81 ABCB6 ADCY8 CACNG3 CACNG2 SLC6A4 SLC6A9 CLCN3 ANO6 SNX25 PKD1 MKLN1 TMEM63A | 1.77e-04 | 1325 | 129 | 20 | GO:0012506 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 2.54e-04 | 201 | 129 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | membrane protein complex | TPCN2 CATSPERD TIMM23 ABCB6 CACHD1 GRM1 RYR1 RYR2 RYR3 STT3A CACNG3 CACNG2 CACNG7 KCND1 ANO6 GLRA1 PKD1 CNTNAP2 C5 ELOVL6 CNGA3 | 3.30e-04 | 1498 | 129 | 21 | GO:0098796 |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 8.25e-04 | 30 | 129 | 3 | GO:0032281 | |
| GeneOntologyCellularComponent | postsynaptic specialization | KALRN GRM1 ADCY8 CACNG3 CACNG2 SLC6A9 CACNG7 PTPRO GLRA1 MKLN1 | 1.14e-03 | 503 | 129 | 10 | GO:0099572 |
| GeneOntologyCellularComponent | migrasome | 1.32e-03 | 9 | 129 | 2 | GO:0140494 | |
| GeneOntologyCellularComponent | junctional membrane complex | 1.32e-03 | 9 | 129 | 2 | GO:0030314 | |
| GeneOntologyCellularComponent | cerebellar mossy fiber | 1.32e-03 | 9 | 129 | 2 | GO:0044300 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | KALRN GRM1 ADCY8 CACNG3 CACNG2 SLC6A9 CACNG7 PTPRO CNTNAP2 MKLN1 | 1.52e-03 | 523 | 129 | 10 | GO:0098984 |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment membrane | 1.60e-03 | 81 | 129 | 4 | GO:0033116 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 1.65e-03 | 10 | 129 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.68e-03 | 277 | 129 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment | 1.83e-03 | 141 | 129 | 5 | GO:0005793 | |
| GeneOntologyCellularComponent | neuronal cell body | TRPV1 KALRN TRPM7 GRM1 LPAR1 ADCY8 CACNG7 KCND1 GLRA1 SLC22A3 CNTNAP2 XRN1 CNGA3 | 1.98e-03 | 835 | 129 | 13 | GO:0043025 |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 2.16e-03 | 88 | 129 | 4 | GO:0016529 | |
| GeneOntologyCellularComponent | endosome | ABCA1 TPCN2 SLC31A2 WDR81 ABCB6 LPAR1 SLC6A4 SLC6A9 ABCG1 CACNG7 CLCN3 SNX25 CNTNAP2 MKLN1 DOP1A TMEM63A | 2.24e-03 | 1167 | 129 | 16 | GO:0005768 |
| GeneOntologyCellularComponent | lysosomal membrane | 2.30e-03 | 462 | 129 | 9 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 2.30e-03 | 462 | 129 | 9 | GO:0098852 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 2.35e-03 | 90 | 129 | 4 | GO:0016328 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 2.70e-03 | 45 | 129 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 2.70e-03 | 45 | 129 | 3 | GO:0033017 | |
| GeneOntologyCellularComponent | beta-catenin destruction complex | 2.82e-03 | 13 | 129 | 2 | GO:0030877 | |
| GeneOntologyCellularComponent | asymmetric synapse | 2.85e-03 | 477 | 129 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 2.87e-03 | 46 | 129 | 3 | GO:0005790 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 2.92e-03 | 157 | 129 | 5 | GO:0098839 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 3.52e-03 | 164 | 129 | 5 | GO:0098982 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 3.64e-03 | 50 | 129 | 3 | GO:0098878 | |
| GeneOntologyCellularComponent | somatodendritic compartment | TRPV1 KALRN TRPM7 GRM1 LPAR1 ADCY8 CACNG3 CACNG2 CACNG7 KCND1 PTPRO GLRA1 SLC22A3 CNTNAP2 XRN1 CNGA3 | 3.70e-03 | 1228 | 129 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | vacuolar membrane | 4.25e-03 | 507 | 129 | 9 | GO:0005774 | |
| GeneOntologyCellularComponent | neuron spine | 4.35e-03 | 247 | 129 | 6 | GO:0044309 | |
| GeneOntologyCellularComponent | excitatory synapse | 4.38e-03 | 107 | 129 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | lysosome | PLBD1 GALC TPCN2 ANPEP SLC31A2 CTSC WDR81 ABCB6 CLCN3 SLC12A4 CLN5 TMEM63A | 4.43e-03 | 811 | 129 | 12 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | PLBD1 GALC TPCN2 ANPEP SLC31A2 CTSC WDR81 ABCB6 CLCN3 SLC12A4 CLN5 TMEM63A | 4.43e-03 | 811 | 129 | 12 | GO:0000323 |
| GeneOntologyCellularComponent | cell body | TRPV1 KALRN TRPM7 GRM1 LPAR1 ADCY8 CACNG7 KCND1 GLRA1 SLC22A3 CNTNAP2 XRN1 CNGA3 | 4.92e-03 | 929 | 129 | 13 | GO:0044297 |
| GeneOntologyCellularComponent | late endosome membrane | 5.10e-03 | 179 | 129 | 5 | GO:0031902 | |
| GeneOntologyCellularComponent | sarcoplasm | 5.48e-03 | 114 | 129 | 4 | GO:0016528 | |
| GeneOntologyCellularComponent | endolysosome membrane | 6.68e-03 | 20 | 129 | 2 | GO:0036020 | |
| GeneOntologyCellularComponent | postsynaptic density | 6.96e-03 | 451 | 129 | 8 | GO:0014069 | |
| MousePheno | abnormal nervous system electrophysiology | SLC12A6 TRPV1 KALRN GRM1 THOC2 ADCY8 RYR2 CACNG2 SLC6A4 SLC6A9 GLRA1 CNTNAP2 | 7.17e-06 | 329 | 106 | 12 | MP:0002272 |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | SLC12A6 TRPV1 ABCA1 ERCC2 GALC EOGT KALRN TRPM7 HACD3 ABCA12 CTSC WDR81 GRM1 CLDN12 ADCY8 RYR1 RYR2 CACNG2 SLC6A4 SLC6A9 PPP2R5C LMO7 GLRA1 CNTNAP2 TTC17 ELOVL6 | 3.41e-05 | 1486 | 106 | 26 | MP:0002067 |
| MousePheno | decreased cholesterol efflux | 3.44e-05 | 9 | 106 | 3 | MP:0003193 | |
| MousePheno | abnormal motor coordination/balance | SLC12A6 TRPV1 GALC EOGT KALRN WDR81 TIMM23 CACHD1 GRM1 THOC2 CLDN12 CACNG2 CERS5 PPP2R5C CLCN3 GLRA1 CNTNAP2 ELOVL6 | 9.17e-05 | 873 | 106 | 18 | MP:0001516 |
| Domain | Ryanodine_rcpt | 2.93e-07 | 3 | 125 | 3 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 2.93e-07 | 3 | 125 | 3 | IPR009460 | |
| Domain | RyR | 2.93e-07 | 3 | 125 | 3 | PF02026 | |
| Domain | RR_TM4-6 | 2.93e-07 | 3 | 125 | 3 | PF06459 | |
| Domain | Ryan_recept | 2.93e-07 | 3 | 125 | 3 | IPR013333 | |
| Domain | Ion_trans_dom | 9.77e-07 | 114 | 125 | 8 | IPR005821 | |
| Domain | Ion_trans | 9.77e-07 | 114 | 125 | 8 | PF00520 | |
| Domain | RIH_assoc-dom | 5.77e-06 | 6 | 125 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 5.77e-06 | 6 | 125 | 3 | PF08709 | |
| Domain | RIH_assoc | 5.77e-06 | 6 | 125 | 3 | PF08454 | |
| Domain | RIH_dom | 5.77e-06 | 6 | 125 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 5.77e-06 | 6 | 125 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 5.77e-06 | 6 | 125 | 3 | IPR015925 | |
| Domain | - | 5.77e-06 | 6 | 125 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 5.77e-06 | 6 | 125 | 3 | PF01365 | |
| Domain | ABC_transporter_CS | 8.64e-06 | 42 | 125 | 5 | IPR017871 | |
| Domain | VDCC_gsu | 1.60e-05 | 8 | 125 | 3 | IPR008368 | |
| Domain | ABC_tran | 1.69e-05 | 48 | 125 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.69e-05 | 48 | 125 | 5 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 1.87e-05 | 49 | 125 | 5 | PS00211 | |
| Domain | ABC_transporter-like | 2.06e-05 | 50 | 125 | 5 | IPR003439 | |
| Domain | MIR | 3.39e-05 | 10 | 125 | 3 | PF02815 | |
| Domain | MIR_motif | 3.39e-05 | 10 | 125 | 3 | IPR016093 | |
| Domain | MIR | 3.39e-05 | 10 | 125 | 3 | PS50919 | |
| Domain | MIR | 3.39e-05 | 10 | 125 | 3 | SM00472 | |
| Domain | KCC1 | 4.44e-05 | 2 | 125 | 2 | IPR000622 | |
| Domain | AAA | 5.23e-05 | 144 | 125 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 5.23e-05 | 144 | 125 | 7 | IPR003593 | |
| Domain | SNF | 2.62e-04 | 19 | 125 | 3 | PF00209 | |
| Domain | Na/ntran_symport | 2.62e-04 | 19 | 125 | 3 | IPR000175 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 2.62e-04 | 19 | 125 | 3 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 2.62e-04 | 19 | 125 | 3 | PS50267 | |
| Domain | KCL_cotranspt | 2.64e-04 | 4 | 125 | 2 | IPR000076 | |
| Domain | TDE1/TMS | 4.39e-04 | 5 | 125 | 2 | IPR005016 | |
| Domain | Serinc | 4.39e-04 | 5 | 125 | 2 | PF03348 | |
| Domain | ELO_CS | 6.55e-04 | 6 | 125 | 2 | IPR030457 | |
| Domain | ConA-like_dom | 6.86e-04 | 219 | 125 | 7 | IPR013320 | |
| Domain | Claudin | 8.48e-04 | 28 | 125 | 3 | IPR006187 | |
| Domain | ELO | 9.13e-04 | 7 | 125 | 2 | PS01188 | |
| Domain | SLC12A_fam | 9.13e-04 | 7 | 125 | 2 | IPR004842 | |
| Domain | ELO | 9.13e-04 | 7 | 125 | 2 | PF01151 | |
| Domain | ELO_fam | 9.13e-04 | 7 | 125 | 2 | IPR002076 | |
| Domain | ERAP1-like_C_dom | 1.21e-03 | 8 | 125 | 2 | IPR024571 | |
| Domain | SLC12_C | 1.21e-03 | 8 | 125 | 2 | IPR018491 | |
| Domain | ERAP1_C | 1.21e-03 | 8 | 125 | 2 | PF11838 | |
| Domain | SLC12 | 1.21e-03 | 8 | 125 | 2 | PF03522 | |
| Domain | PMP22_Claudin | 2.41e-03 | 40 | 125 | 3 | PF00822 | |
| Domain | SPRY | 2.77e-03 | 87 | 125 | 4 | SM00449 | |
| Domain | ABC_A | 2.81e-03 | 12 | 125 | 2 | IPR026082 | |
| Domain | Peptidase_M1 | 2.81e-03 | 12 | 125 | 2 | IPR001930 | |
| Domain | Peptidase_M1_N | 3.30e-03 | 13 | 125 | 2 | IPR014782 | |
| Domain | Peptidase_M1 | 3.30e-03 | 13 | 125 | 2 | PF01433 | |
| Domain | PMP22/EMP/MP20/Claudin | 3.38e-03 | 45 | 125 | 3 | IPR004031 | |
| Domain | SPRY | 3.67e-03 | 94 | 125 | 4 | PF00622 | |
| Domain | SPRY_dom | 3.67e-03 | 94 | 125 | 4 | IPR003877 | |
| Domain | B30.2/SPRY | 3.81e-03 | 95 | 125 | 4 | IPR001870 | |
| Domain | B302_SPRY | 3.81e-03 | 95 | 125 | 4 | PS50188 | |
| Domain | Dynein_heavy_chain_D4_dom | 3.84e-03 | 14 | 125 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 3.84e-03 | 14 | 125 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.84e-03 | 14 | 125 | 2 | IPR013602 | |
| Domain | DHC_N2 | 3.84e-03 | 14 | 125 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 3.84e-03 | 14 | 125 | 2 | IPR011704 | |
| Domain | MT | 3.84e-03 | 14 | 125 | 2 | PF12777 | |
| Domain | AAA_8 | 3.84e-03 | 14 | 125 | 2 | PF12780 | |
| Domain | AAA_5 | 3.84e-03 | 14 | 125 | 2 | PF07728 | |
| Domain | DHC_fam | 4.41e-03 | 15 | 125 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 4.41e-03 | 15 | 125 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.41e-03 | 15 | 125 | 2 | IPR004273 | |
| Domain | NA_NEUROTRAN_SYMP_2 | 6.34e-03 | 18 | 125 | 2 | PS00754 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC12A6 TRPV1 ABCA1 LMF1 TPCN2 TRPM7 ABCA12 ATP13A1 SLC6A19 ABCB6 ADCY8 RYR1 RYR2 RYR3 SLC6A9 ABCG1 CLCN3 SLC12A4 ANO6 SLC22A3 | 2.14e-07 | 736 | 101 | 20 | M27287 |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 8.87e-07 | 106 | 101 | 8 | M27200 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC12A6 TRPV1 ABCA1 LMF1 TPCN2 TRPM7 ABCA12 ATP13A1 SLC6A19 ABCB6 RYR1 RYR2 RYR3 SLC6A9 ABCG1 SLC12A4 ANO6 SLC22A3 | 1.42e-06 | 681 | 101 | 18 | MM14985 |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 6.44e-06 | 183 | 101 | 9 | M997 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 6.82e-06 | 99 | 101 | 7 | MM14910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 1.35e-05 | 21 | 101 | 4 | M47950 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING | 1.35e-05 | 21 | 101 | 4 | M47949 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.49e-05 | 44 | 101 | 5 | M11911 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.79e-05 | 176 | 101 | 8 | MM15718 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 4.46e-05 | 90 | 101 | 6 | M835 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 5.65e-05 | 11 | 101 | 3 | M47958 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 9.69e-05 | 13 | 101 | 3 | M39589 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 2.53e-04 | 79 | 101 | 5 | M17673 | |
| Pathway | REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE | 2.69e-04 | 18 | 101 | 3 | MM14759 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.18e-04 | 19 | 101 | 3 | M47760 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 3.19e-04 | 83 | 101 | 5 | M8728 | |
| Pathway | WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS | 3.49e-04 | 47 | 101 | 4 | M39853 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | PLBD1 GALC SPTSSA HACD3 CH25H ELOVL1 GPAT3 CERS5 BMX PLA2G4C FDFT1 FAR1 ELOVL6 | 4.71e-04 | 620 | 101 | 13 | MM15193 |
| Pathway | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | 4.98e-04 | 22 | 101 | 3 | MM15451 | |
| Pathway | WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS | 5.16e-04 | 52 | 101 | 4 | MM15920 | |
| Pathway | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | 6.48e-04 | 24 | 101 | 3 | M1016 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 7.32e-04 | 25 | 101 | 3 | M47948 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 8.59e-04 | 103 | 101 | 5 | MM15196 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | PLBD1 ABCA1 GALC SPTSSA HACD3 CH25H ELOVL1 GPAT3 CERS5 BMX PLA2G4C FDFT1 FAR1 ELOVL6 | 9.77e-04 | 757 | 101 | 14 | M27451 |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.04e-03 | 7 | 101 | 2 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.04e-03 | 7 | 101 | 2 | MM15081 | |
| Pathway | WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES | 1.20e-03 | 111 | 101 | 5 | M48065 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 1.39e-03 | 31 | 101 | 3 | MM15154 | |
| Pathway | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | 1.52e-03 | 32 | 101 | 3 | MM15446 | |
| Pathway | REACTOME_SERINE_BIOSYNTHESIS | 1.77e-03 | 9 | 101 | 2 | M27959 | |
| Pathway | REACTOME_SERINE_BIOSYNTHESIS | 1.77e-03 | 9 | 101 | 2 | MM15707 | |
| Pathway | REACTOME_HYDROLYSIS_OF_LPC | 1.77e-03 | 9 | 101 | 2 | M26960 | |
| Pathway | REACTOME_HYDROLYSIS_OF_LPC | 1.77e-03 | 9 | 101 | 2 | MM14582 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 18403125 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 7876312 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 5.10e-08 | 3 | 130 | 3 | 10788707 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 5.10e-08 | 3 | 130 | 3 | 7621815 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 5.10e-08 | 3 | 130 | 3 | 10473538 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 5.10e-08 | 3 | 130 | 3 | 9204703 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 5.10e-08 | 3 | 130 | 3 | 12213830 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 9242641 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 25239916 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 18643873 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 11159936 | ||
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 5.10e-08 | 3 | 130 | 3 | 4600883 | |
| Pubmed | 5.10e-08 | 3 | 130 | 3 | 7635066 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 2.04e-07 | 4 | 130 | 3 | 23413940 | |
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 9607712 | ||
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 23482488 | ||
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 18206662 | ||
| Pubmed | 2.04e-07 | 4 | 130 | 3 | 9384575 | ||
| Pubmed | 3.51e-07 | 39 | 130 | 5 | 23864651 | ||
| Pubmed | 5.08e-07 | 5 | 130 | 3 | 23918386 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 5.08e-07 | 5 | 130 | 3 | 19011160 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | SLC12A6 LMF1 EOGT TPCN2 SPTSSA HACD3 LMBR1 FRYL CLDN12 STT3A ZNF331 DOCK5 ABCG1 CSNK1A1 TLL1 SLC22A3 MKLN1 TTC17 DOP1A TMEM63A | 7.05e-07 | 1489 | 130 | 20 | 28611215 |
| Pubmed | 1.01e-06 | 6 | 130 | 3 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 1.01e-06 | 6 | 130 | 3 | 26025922 | |
| Pubmed | 1.01e-06 | 6 | 130 | 3 | 23463619 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 1.01e-06 | 6 | 130 | 3 | 14592808 | |
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.01e-06 | 6 | 130 | 3 | 25966694 | |
| Pubmed | 1.01e-06 | 6 | 130 | 3 | 19009018 | ||
| Pubmed | 1.01e-06 | 6 | 130 | 3 | 20519450 | ||
| Pubmed | Interferon-mediated reprogramming of membrane cholesterol to evade bacterial toxins. | 1.01e-06 | 6 | 130 | 3 | 32514064 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.01e-06 | 6 | 130 | 3 | 16844763 | |
| Pubmed | 1.77e-06 | 7 | 130 | 3 | 11860456 | ||
| Pubmed | 1.77e-06 | 7 | 130 | 3 | 20962236 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | MYH7 TPCN2 SLC31A2 ATP13A1 CH25H GRM1 LPAR1 YIF1A PKD1 CCR8 TMEM19 TMEM63A PIGM | 2.30e-06 | 697 | 130 | 13 | 28298427 |
| Pubmed | ORAI1, STIM1/2, and RYR1 shape subsecond Ca2+ microdomains upon T cell activation. | 2.82e-06 | 8 | 130 | 3 | 30563862 | |
| Pubmed | 2.82e-06 | 8 | 130 | 3 | 11784029 | ||
| Pubmed | 2.82e-06 | 8 | 130 | 3 | 27471270 | ||
| Pubmed | Calcium channel gamma subunits: a functionally diverse protein family. | 2.82e-06 | 8 | 130 | 3 | 17652770 | |
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 2.82e-06 | 8 | 130 | 3 | 19033399 | |
| Pubmed | SLC12A6 CLGN HACD3 ATP13A1 ELOVL1 GPAT3 TIMM23 STT3A YIF1A CSNK1A1L SLC12A4 CSNK1A1 ANO6 TTC17 FAR1 | 2.95e-06 | 952 | 130 | 15 | 38569033 | |
| Pubmed | Morphology-based mammalian stem cell tests reveal potential developmental toxicity of donepezil. | 3.06e-06 | 27 | 130 | 4 | 25269881 | |
| Pubmed | 4.22e-06 | 9 | 130 | 3 | 11170751 | ||
| Pubmed | 6.01e-06 | 10 | 130 | 3 | 32072744 | ||
| Pubmed | 1.10e-05 | 12 | 130 | 3 | 19095005 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 1.25e-05 | 38 | 130 | 4 | 30786075 | |
| Pubmed | Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters. | 1.39e-05 | 2 | 130 | 2 | 34031912 | |
| Pubmed | Recent advances in the regulation of ABCA1 and ABCG1 by lncRNAs. | 1.39e-05 | 2 | 130 | 2 | 33545111 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 23354688 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 31167810 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 16192285 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 22315310 | ||
| Pubmed | Tissue-specific distribution of mouse casein kinase I alpha mRNA. | 1.39e-05 | 2 | 130 | 2 | 9522121 | |
| Pubmed | TARP redundancy is critical for maintaining AMPA receptor function. | 1.39e-05 | 2 | 130 | 2 | 18753375 | |
| Pubmed | TARP γ-7 selectively enhances synaptic expression of calcium-permeable AMPARs. | 1.39e-05 | 2 | 130 | 2 | 23872597 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 9489997 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 17259277 | ||
| Pubmed | CSNK1A1/CK1α suppresses autoimmunity by restraining the CGAS-STING1 signaling. | 1.39e-05 | 2 | 130 | 2 | 37723657 | |
| Pubmed | Casein Kinase 1α Regulates Testosterone Synthesis and Testis Development in Adult Mice. | 1.39e-05 | 2 | 130 | 2 | 36929849 | |
| Pubmed | [Regulation of ABCA1 and ABCG1 gene expression in the intraabdominal adipose tissue]. | 1.39e-05 | 2 | 130 | 2 | 27420620 | |
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 1.39e-05 | 2 | 130 | 2 | 12640042 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 34837967 | ||
| Pubmed | Genetic variations in ABCA1/G1 associated with plasma lipid levels and risk of ischemic stroke. | 1.39e-05 | 2 | 130 | 2 | 35219812 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 1.39e-05 | 2 | 130 | 2 | 14722100 | |
| Pubmed | Structural and functional interactions within ryanodine receptor. | 1.39e-05 | 2 | 130 | 2 | 26009179 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 18490524 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 24462739 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 32899693 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 14592949 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 8898078 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 10221464 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 27702832 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 12584728 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 35695793 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 14550562 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 23880356 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 17082211 | ||
| Pubmed | Exploring the role of casein kinase 1α splice variants across cancer cell lines. | 1.39e-05 | 2 | 130 | 2 | 38852281 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 9799464 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 16730733 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 23690993 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 31101336 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 30864945 | ||
| Pubmed | Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia. | 1.39e-05 | 2 | 130 | 2 | 31835175 | |
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 1.39e-05 | 2 | 130 | 2 | 15033925 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 19839639 | ||
| Pubmed | Knockdown of Csnk1a1 results in preimplantation developmental arrest in mice. | 1.39e-05 | 2 | 130 | 2 | 36542875 | |
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 1.39e-05 | 2 | 130 | 2 | 17118445 | |
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 1.39e-05 | 2 | 130 | 2 | 11500519 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 22466164 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 17121837 | ||
| Pubmed | Lipid efflux by the ATP-binding cassette transporters ABCA1 and ABCG1. | 1.39e-05 | 2 | 130 | 2 | 16798073 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 12032171 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 1.39e-05 | 2 | 130 | 2 | 21531043 | |
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 21111593 | ||
| Pubmed | 1.39e-05 | 2 | 130 | 2 | 16678258 | ||
| Pubmed | Association of SLC6A4 5-HTTLPR and TRPV1 945G>C with functional dyspepsia in Korea. | 1.39e-05 | 2 | 130 | 2 | 24720453 | |
| Interaction | TTYH1 interactions | SLC12A6 TPCN2 TRPM7 HACD3 LMBR1 ABCB6 LPAR1 CERS5 SLC12A4 ANO6 SNX25 TMEM63A PIGM | 4.69e-08 | 300 | 125 | 13 | int:TTYH1 |
| Interaction | OR10H2 interactions | 3.14e-07 | 72 | 125 | 7 | int:OR10H2 | |
| Interaction | CD3D interactions | 9.86e-07 | 85 | 125 | 7 | int:CD3D | |
| Interaction | CCR6 interactions | 1.93e-05 | 89 | 125 | 6 | int:CCR6 | |
| Interaction | POMK interactions | 4.95e-05 | 271 | 125 | 9 | int:POMK | |
| Interaction | NKAIN1 interactions | 5.20e-05 | 65 | 125 | 5 | int:NKAIN1 | |
| Interaction | LGALS3 interactions | SLC12A6 LPAR1 ADCY8 CLCN3 SLC12A4 PTPRO SERINC1 CSNK1A1 FGB TMEM63A | 5.22e-05 | 340 | 125 | 10 | int:LGALS3 |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.04e-07 | 3 | 86 | 3 | 287 | |
| GeneFamily | Solute carriers | SLC12A6 SLC31A2 SLC6A19 SLC35C2 SLC6A4 SLC6A9 SLC12A4 SLC22A14 SLC22A3 SLC22A20P | 1.79e-05 | 395 | 86 | 10 | 752 |
| GeneFamily | Calcium voltage-gated channel subunits | 2.50e-04 | 26 | 86 | 3 | 253 | |
| GeneFamily | ATP binding cassette subfamily A | 1.96e-03 | 14 | 86 | 2 | 805 | |
| GeneFamily | Dyneins, axonemal | 2.90e-03 | 17 | 86 | 2 | 536 | |
| Coexpression | FAN_EMBRYONIC_CTX_OLIG | GALC SPTSSA SLC31A2 ELOVL1 FRYL LPAR1 BROX SLC6A9 PLA2G4C CLCN3 SERINC1 FDFT1 TRIM62 FAR1 ELOVL6 TMEM63A | 9.74e-07 | 754 | 129 | 16 | M39037 |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP | 6.92e-06 | 200 | 129 | 8 | M9499 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | TPCN2 HACD3 ATP13A1 SPPL3 ELOVL1 CLDN12 STT3A CERS5 SF3B3 SLC12A4 SERINC1 ANO6 TMEM19 TMEM63A | 6.97e-06 | 681 | 129 | 14 | M5314 |
| Coexpression | HALLMARK_PROTEIN_SECRETION | 8.16e-06 | 96 | 129 | 6 | M5910 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | TPCN2 HACD3 ATP13A1 SPPL3 ELOVL1 CLDN12 STT3A CERS5 SF3B3 SLC12A4 SERINC1 ANO6 TMEM19 TMEM63A | 9.98e-06 | 703 | 129 | 14 | MM1055 |
| Coexpression | HALLMARK_KRAS_SIGNALING_DN | 6.18e-05 | 200 | 129 | 7 | M5956 | |
| Coexpression | KAAB_FAILED_HEART_VENTRICLE_DN | 6.53e-05 | 44 | 129 | 4 | M15188 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP | 6.76e-05 | 86 | 129 | 5 | M19610 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-09 | 160 | 131 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-09 | 160 | 131 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-08 | 184 | 131 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-08 | 184 | 131 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-08 | 184 | 131 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.87e-07 | 148 | 131 | 7 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-06 | 181 | 131 | 7 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-06 | 200 | 131 | 7 | a443e475e7a10c26a6173d1af961de6219e0e567 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.16e-06 | 200 | 131 | 7 | ed785a6d08ca2b350dc3307b587eadfb2886d1f9 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 6.17e-06 | 153 | 131 | 6 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 167 | 131 | 6 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 169 | 131 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L1-6_PVALB_SCUBE3_(Chandelier_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-05 | 173 | 131 | 6 | d17e50dc400098374af626803dec1241ec566769 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 175 | 131 | 6 | 9a96a946db731ba24c9be34bedebf1f4a1372b9e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 175 | 131 | 6 | 54c1f080195ad8392a095e83b56a4b54073d4c0d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 175 | 131 | 6 | 2b51406a2c2daa13ab4ed283ede038cd11d9e641 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.37e-05 | 176 | 131 | 6 | 4843af68f013732c28a8b8edad30d5fa0f2b084b | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Macrophage|bone_marrow / Manually curated celltypes from each tissue | 1.46e-05 | 178 | 131 | 6 | 11a338032b59b936c5e65517c4160f7dd47a2cda | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 181 | 131 | 6 | 89c551de26de047c316c91ac1d97bdf728a33d9e | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-05 | 183 | 131 | 6 | 103c4c4595d8daa677679fd2fa1e99cd398e56dd | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|lymph-node_spleen / Manually curated celltypes from each tissue | 1.88e-05 | 186 | 131 | 6 | 17eec1efad1f5e9ced1eb6bc9eb5dd7ded789c61 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 187 | 131 | 6 | 9c9ae8725905ba0cfe407878006ed06c2480fb72 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-05 | 187 | 131 | 6 | 9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.99e-05 | 188 | 131 | 6 | dc52dd2957be3f40001f0a56f3d9ac9d66ea466e | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.99e-05 | 188 | 131 | 6 | 2ef08313087e91985bcffc46c3798470cdeec49c | |
| ToppCell | droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.99e-05 | 188 | 131 | 6 | 1f1604b6dc0a8ad0be3d9aac0bef448459c22465 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 188 | 131 | 6 | 5b69de5baaac45a6d4daa1dbfcb70a7b2ae744ac | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.11e-05 | 190 | 131 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Endothelial-Lymphatic|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.11e-05 | 190 | 131 | 6 | 8d6ec2fc0af19a5cb16fff34f8b131b71b33d45f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.24e-05 | 192 | 131 | 6 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-05 | 193 | 131 | 6 | 040f6bb42aa41d0921371fdda1cc0912c4fe1930 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-05 | 193 | 131 | 6 | e468287c8b30c56d1de65e8347ade233ba6cf584 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.67e-05 | 198 | 131 | 6 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.67e-05 | 198 | 131 | 6 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.74e-05 | 199 | 131 | 6 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-TRAM-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.74e-05 | 199 | 131 | 6 | 5e4f02cfb90912e83257ed20f69c12650d28619e | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.82e-05 | 200 | 131 | 6 | eac33be484dc443794e66e473f03e98406c2983e | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 200 | 131 | 6 | efdbd1273b07d9fe957380e347b5b6b45db0a271 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-05 | 200 | 131 | 6 | 9ca86928fceaa1fefd0f9ffcfa5cc0a210ee5792 | |
| ToppCell | Cerebellum-Neuronal-Excitatory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.85e-05 | 128 | 131 | 5 | c30ba14320e9b98c9af9e4cd5a8c55380bb9ffa9 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 4.46e-05 | 132 | 131 | 5 | 617644597726e881cd343e57f6edb5a98473b421 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 7.68e-05 | 148 | 131 | 5 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.68e-05 | 148 | 131 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.18e-05 | 150 | 131 | 5 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | CV-Healthy-3|Healthy / Virus stimulation, Condition and Cluster | 9.26e-05 | 154 | 131 | 5 | 26bf81a86700db7e65c2384ffe94ed4253ea4047 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 157 | 131 | 5 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 157 | 131 | 5 | 5d08ff0ba9d3df9cc30f13cab2d2b395ea6f3446 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 157 | 131 | 5 | ad9c9b7dfeee3ae46e7e593c51a0407df12195b4 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.08e-04 | 159 | 131 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 159 | 131 | 5 | 3bab00f8fb7d9232538e50f83dd0fd70ddd16819 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 160 | 131 | 5 | 5bec867def73fa8531f8dad611679f4b44f573bd | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.14e-04 | 161 | 131 | 5 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.21e-04 | 163 | 131 | 5 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 163 | 131 | 5 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 163 | 131 | 5 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 165 | 131 | 5 | b671c6a950e70f64776c2104baccb3dc2bb6a1ba | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 165 | 131 | 5 | 6d315e0734079ad05336cc2c3f24d870c9105bc8 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 165 | 131 | 5 | 84f5597b1bb75f42de9a224196bb8ac198bbe3bf | |
| ToppCell | P07-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.32e-04 | 166 | 131 | 5 | 021b9344de7957762f81b09a647504b8c8289cf1 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 168 | 131 | 5 | a74c8a9e3299183fba31ce3053ef325b5dbcd104 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 168 | 131 | 5 | dae37b316ce80dfe4236c4ed7f0d4e7c340fa7b6 | |
| ToppCell | Endothelial-B-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.39e-04 | 168 | 131 | 5 | 4977c3837fbb1f36c89fddd5764e37290ac25ad8 | |
| ToppCell | COVID-19-Heart-Adipocyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.43e-04 | 169 | 131 | 5 | bd39f85b48207955f80ca120a11e15a0124117b9 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.43e-04 | 169 | 131 | 5 | ec23caecbb0d969307e33e9df8499ddcd1420305 | |
| ToppCell | P07-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.43e-04 | 169 | 131 | 5 | 53e863de064d44e1d36e21fb3dbba37ae020f6e9 | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.47e-04 | 170 | 131 | 5 | 6c0619cbe2f01a6de18da0a137f92bda0cbdf075 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.47e-04 | 170 | 131 | 5 | d0ed3a8a7ad96c05641ec409b0a69c4fb094893c | |
| ToppCell | P03-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.47e-04 | 170 | 131 | 5 | 3fd37e9b377d6485cea1262c31a8507d18a78514 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 171 | 131 | 5 | 8bed33f61f7d12a1ac4fba33f730d839f5ee7bef | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 131 | 5 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.55e-04 | 172 | 131 | 5 | c8ea80042faf923b08ff03d73100533d521d73ef | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 131 | 5 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 131 | 5 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 131 | 5 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 131 | 5 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 173 | 131 | 5 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Lymphatic_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.64e-04 | 174 | 131 | 5 | d551bc29afef071adf4c9bb80345352ec33441d8 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 175 | 131 | 5 | 0801cccec6915aefc135262fc74580280fd51aa5 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.68e-04 | 175 | 131 | 5 | 8a4ed775ff973123dbcfe9c809959d11a62450c9 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 175 | 131 | 5 | 09163e7030f76d706eccabdb1d5ec45f8412aa75 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-04 | 175 | 131 | 5 | f6e1d7297a4dbb38e1ab4f738d91f0e62abaee69 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 176 | 131 | 5 | 3766e0533b103ec92ac75eba3df02e287efc53fa | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 176 | 131 | 5 | aa1bada2175d8370fc71939a607407155259d195 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Drd1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.73e-04 | 176 | 131 | 5 | 3c76a5c4ca2b378667cb155fbb9675519572b35d | |
| ToppCell | COVID-19-Heart-Lymph_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.78e-04 | 177 | 131 | 5 | 326fde0734ef0d7272693966d346ca479b9d8147 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-04 | 177 | 131 | 5 | 75cb2067a3f2d1b5a964890b02b604d1e79bd163 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 178 | 131 | 5 | 8c5e9fab7b55a654ccaabf2c4d02397399d94616 | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.82e-04 | 178 | 131 | 5 | 499640cfb1063aa40343ec1563e40fe4645466fb | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.82e-04 | 178 | 131 | 5 | 851fdcf1451880a048885cc6677b4edfff6aee4c | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.82e-04 | 178 | 131 | 5 | 1a3b3b73e81ceb26cec8153cd1bdd7b446887a71 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 179 | 131 | 5 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | COVID-19-Heart-Lymph_EC|Heart / Disease (COVID-19 only), tissue and cell type | 1.87e-04 | 179 | 131 | 5 | 411620201a860716a8773b92f50f7b94ef34a586 | |
| ToppCell | ILEUM-non-inflamed-(7)_Lymphatics|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.87e-04 | 179 | 131 | 5 | 99777a8931356d1206b8ab22aaa1b1d5a600b809 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 181 | 131 | 5 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | Control-Myeloid-Alveolar_macrophages|Control / group, cell type (main and fine annotations) | 1.97e-04 | 181 | 131 | 5 | 8d2102c8c86c59a82610f26f90946b290552e666 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 181 | 131 | 5 | cef034030e6b029a49ae56be37ea1fac1a5c350e | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-04 | 181 | 131 | 5 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.97e-04 | 181 | 131 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.02e-04 | 182 | 131 | 5 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-04 | 182 | 131 | 5 | 22d6f4790950508e8aa27e02a8133af5f53f13c8 | |
| Drug | lanthanum | TPCN2 TRPM7 GPAT3 ADCY8 RYR1 RYR2 RYR3 CACNG3 CACNG2 CACNG7 KCND1 PKD1 | 1.51e-11 | 136 | 127 | 12 | CID000023926 |
| Drug | verapamil | MYH7 ABCA1 TPCN2 ABCA12 ABCB6 ADCY8 RYR1 RYR2 RYR3 CACNG3 CACNG2 ABCG1 CACNG7 CLCN3 KCND1 SLC22A3 PKD1 ABCC12 ART5 | 3.27e-11 | 490 | 127 | 19 | CID000002520 |
| Drug | nitrendipine | 1.88e-10 | 98 | 127 | 10 | CID000004507 | |
| Drug | Cinildipine | 8.51e-10 | 56 | 127 | 8 | CID000002752 | |
| Drug | nilvadipine | 1.50e-09 | 60 | 127 | 8 | CID000004494 | |
| Drug | lercanidipine | 2.25e-09 | 63 | 127 | 8 | CID000065866 | |
| Drug | manidipine | 3.08e-09 | 95 | 127 | 9 | CID000004008 | |
| Drug | gallopamil | 3.71e-09 | 67 | 127 | 8 | CID000001234 | |
| Drug | AC1L2AC7 | 4.72e-09 | 69 | 127 | 8 | CID000068733 | |
| Drug | CAS 298-57-7 | 7.44e-09 | 73 | 127 | 8 | CID000002761 | |
| Drug | ethosuximide | 8.31e-09 | 74 | 127 | 8 | CID000003291 | |
| Drug | nimodipine | 8.90e-09 | 145 | 127 | 10 | CID000004497 | |
| Drug | Bay K 8644 | 1.23e-08 | 150 | 127 | 10 | CID000002303 | |
| Drug | nisoldipine | 1.27e-08 | 78 | 127 | 8 | CID000004499 | |
| Drug | gadolinium | TRPV1 GALC TRPM7 GRM1 RYR1 RYR2 RYR3 CACNG2 CACNG7 PKD1 ELOVL6 | 1.59e-08 | 199 | 127 | 11 | CID000023982 |
| Drug | CNS 1145 | 2.62e-08 | 33 | 127 | 6 | CID000190902 | |
| Drug | IHC-64 | 2.62e-08 | 33 | 127 | 6 | CID000162753 | |
| Drug | gabapentin | 3.85e-08 | 169 | 127 | 10 | CID000003446 | |
| Drug | AC1NUZ8M | 4.72e-08 | 92 | 127 | 8 | CID000073211 | |
| Drug | mibefradil | 6.79e-08 | 64 | 127 | 7 | CID000060662 | |
| Drug | isradipine | 9.09e-08 | 100 | 127 | 8 | CID000003784 | |
| Drug | baclofen | 1.22e-07 | 191 | 127 | 10 | CID000002284 | |
| Drug | NSC759576 | 1.22e-07 | 191 | 127 | 10 | CID000003075 | |
| Drug | Dantrolene-13C3 | 1.26e-07 | 145 | 127 | 9 | CID000002951 | |
| Drug | loperamide | 1.33e-07 | 105 | 127 | 8 | CID000003954 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | SLC12A6 ADCY8 RYR1 RYR2 RYR3 CACNG2 SLC6A4 CACNG7 SLC12A4 PKD1 ART5 CNGA3 | 1.63e-07 | 308 | 127 | 12 | CID000001915 |
| Drug | cis-diammineplatinum(II | 1.69e-07 | 3 | 127 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 1.69e-07 | 3 | 127 | 3 | CID002750949 | |
| Drug | 8N3-cADPR | 1.69e-07 | 3 | 127 | 3 | CID000127713 | |
| Drug | aminodantrolene | 1.69e-07 | 3 | 127 | 3 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 1.69e-07 | 3 | 127 | 3 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 1.69e-07 | 3 | 127 | 3 | CID005748312 | |
| Drug | halothane | MYH7 TPCN2 CH25H ADCY8 RYR1 RYR2 RYR3 CACNG3 CACNG2 CACNG7 GLRA1 PKD1 | 2.01e-07 | 314 | 127 | 12 | CID000003562 |
| Drug | lamotrigine | 2.88e-07 | 116 | 127 | 8 | CID000003878 | |
| Drug | AC1L1KS5 | TRPV1 TRPM7 GRM1 LPAR1 ADCY8 RYR1 RYR2 RYR3 CACNG2 CACNG7 PKD1 ART5 | 3.88e-07 | 334 | 127 | 12 | CID000005631 |
| Drug | felodipine | 4.63e-07 | 169 | 127 | 9 | CID000003333 | |
| Drug | bepridil | 5.44e-07 | 126 | 127 | 8 | CID000002351 | |
| Drug | pimozide | 5.77e-07 | 127 | 127 | 8 | CID000016362 | |
| Drug | PCB74 | 6.75e-07 | 4 | 127 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 6.75e-07 | 4 | 127 | 3 | CID006444275 | |
| Drug | SC 38249 | 6.75e-07 | 4 | 127 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 6.75e-07 | 4 | 127 | 3 | CID000035682 | |
| Drug | IAA-94 | 1.16e-06 | 61 | 127 | 6 | CID000003667 | |
| Drug | 3-isoreserpine | 1.23e-06 | 190 | 127 | 9 | CID000005052 | |
| Drug | dihydropyridine | 1.40e-06 | 193 | 127 | 9 | CID000104822 | |
| Drug | isovalerate | 1.42e-06 | 143 | 127 | 8 | CID000010430 | |
| Drug | nicardipine | 1.58e-06 | 145 | 127 | 8 | CID000004473 | |
| Drug | procaine | 2.36e-06 | 153 | 127 | 8 | CID000004914 | |
| Drug | methylcoumarin | 2.66e-06 | 18 | 127 | 4 | CID000007092 | |
| Drug | caffeine | ERCC2 TPCN2 CH25H GRM1 ADCY8 RYR1 RYR2 RYR3 STT3A CACNG3 CACNG2 CACNG7 PKD1 XRN1 | 3.19e-06 | 562 | 127 | 14 | CID000002519 |
| Drug | chloro-m-cresol | 3.35e-06 | 6 | 127 | 3 | CID000012008 | |
| Drug | MBED | 3.35e-06 | 6 | 127 | 3 | CID000129958 | |
| Drug | AC1O528X | 3.35e-06 | 6 | 127 | 3 | CID006475857 | |
| Drug | NSC114784 | 3.35e-06 | 6 | 127 | 3 | CID000419425 | |
| Drug | nifedipine | MYH7 TPCN2 CH25H GRM1 RYR1 RYR2 RYR3 CACNG3 CACNG2 CACNG7 PKD1 ART5 | 3.74e-06 | 415 | 127 | 12 | CID000004485 |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 5.33e-06 | 79 | 127 | 6 | CID005287890 | |
| Drug | lavendustin A | 5.39e-06 | 171 | 127 | 8 | CID000003894 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 5.84e-06 | 7 | 127 | 3 | CID009547999 | |
| Drug | Azumoleno | 5.84e-06 | 7 | 127 | 3 | CID000056259 | |
| Drug | Br2BAPTA | 5.84e-06 | 7 | 127 | 3 | CID003081001 | |
| Drug | riluzole | 6.13e-06 | 174 | 127 | 8 | CID000005070 | |
| Drug | carbachol | MYH7 TPCN2 TRPM7 CTSC GRM1 ADCY8 RYR1 RYR2 RYR3 CACNG3 CACNG2 CACNG7 PKD1 ELOVL6 ART5 | 7.00e-06 | 688 | 127 | 15 | CID000002551 |
| Drug | cadmium | TPCN2 ANPEP GRM1 RYR1 RYR3 CACNG3 CACNG2 CACNG7 KCND1 PKD1 C5 FAR1 | 7.25e-06 | 443 | 127 | 12 | CID000002514 |
| Drug | T0702 | 1.07e-05 | 25 | 127 | 4 | CID000005908 | |
| Drug | lactosyl lysosphingolipid | 1.39e-05 | 9 | 127 | 3 | CID006439268 | |
| Drug | BAPNA | 1.66e-05 | 57 | 127 | 5 | CID000013494 | |
| Drug | isotetrandrine | 1.75e-05 | 97 | 127 | 6 | CID000005422 | |
| Drug | PCB 95 | 1.98e-05 | 10 | 127 | 3 | CID000038012 | |
| Drug | glutamate | TRPV1 ANPEP TRPM7 GRM1 ADCY8 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 GLRA1 PKD1 ART5 | 2.55e-05 | 962 | 127 | 17 | CID000000611 |
| Drug | PCB 66 | 2.71e-05 | 11 | 127 | 3 | CID000036185 | |
| Drug | R 478 | 2.71e-05 | 11 | 127 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 2.71e-05 | 11 | 127 | 3 | CID003081323 | |
| Drug | CHAPS detergent | 3.02e-05 | 158 | 127 | 7 | CID000107670 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 3.09e-05 | 2 | 127 | 2 | ctd:C005147 | |
| Drug | phenytoin | 3.24e-05 | 219 | 127 | 8 | CID000001775 | |
| Drug | Ryanodine | 3.59e-05 | 12 | 127 | 3 | ctd:D012433 | |
| Drug | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 3.76e-05 | 34 | 127 | 4 | ctd:D017878 | |
| Drug | potassium | SLC12A6 TPCN2 GRM1 ADCY8 RYR1 RYR2 RYR3 CACNG3 CACNG2 CACNG7 CLCN3 SLC12A4 KCND1 PKD1 CNTNAP2 C1D ART5 | 4.58e-05 | 1008 | 127 | 17 | CID000000813 |
| Drug | AC1NBU2S | 5.05e-05 | 117 | 127 | 6 | CID004473765 | |
| Drug | mag-fura-2 | 5.29e-05 | 37 | 127 | 4 | CID000123839 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 5.29e-05 | 37 | 127 | 4 | CID000009643 | |
| Drug | papaverine | 6.00e-05 | 176 | 127 | 7 | CID000004680 | |
| Drug | nickel | TPCN2 TRPM7 ADCY8 RYR1 RYR2 RYR3 CACNG3 CACNG2 CACNG7 LMO7 PKD1 ART5 | 6.27e-05 | 552 | 127 | 12 | CID000000934 |
| Drug | fluo-3 | 6.37e-05 | 122 | 127 | 6 | CID000104978 | |
| Drug | cobalt-60 | 6.85e-05 | 390 | 127 | 10 | CID000061492 | |
| Drug | amiloride | 7.04e-05 | 315 | 127 | 9 | CID000016230 | |
| Drug | gamma-aminobutyric acid | GRM1 RYR1 RYR2 RYR3 CACNG2 SLC6A4 SLC6A9 CACNG7 CLCN3 GLRA1 PKD1 | 7.21e-05 | 474 | 127 | 11 | CID000000119 |
| Drug | FPL 64176 | 7.34e-05 | 15 | 127 | 3 | CID000003423 | |
| Drug | Gvapspat amide | 7.34e-05 | 15 | 127 | 3 | CID000125015 | |
| Drug | sodium | SLC12A6 TRPV1 TRPM7 ADCY8 RYR1 RYR2 RYR3 SLC6A4 SLC6A9 CLCN3 SLC12A4 GLRA1 SLC22A3 PKD1 CNTNAP2 ART5 | 7.36e-05 | 944 | 127 | 16 | CID000000923 |
| Drug | NSC7524 | 7.41e-05 | 182 | 127 | 7 | CID000005657 | |
| Drug | N-methyl-DL-aspartic acid | TPCN2 TRPM7 GRM1 ADCY8 RYR1 RYR2 RYR3 CACNG3 CACNG2 SLC6A9 CACNG7 GLRA1 PKD1 | 7.74e-05 | 655 | 127 | 13 | CID000004376 |
| Drug | Dantrolene | 7.97e-05 | 41 | 127 | 4 | ctd:D003620 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 9.23e-05 | 3 | 127 | 2 | CID000080262 | |
| Drug | form bis | 9.23e-05 | 3 | 127 | 2 | CID000006411 | |
| Drug | flubendiamide | 9.23e-05 | 3 | 127 | 2 | CID011193251 | |
| Drug | AC1L96VB | 1.00e-04 | 191 | 127 | 7 | CID000439200 | |
| Drug | Calcium | 1.02e-04 | 493 | 127 | 11 | ctd:D002118 | |
| Drug | XeC compound | 1.08e-04 | 84 | 127 | 5 | CID000005701 | |
| Drug | kazinol B | 1.09e-04 | 17 | 127 | 3 | CID000480869 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 7.07e-08 | 3 | 123 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 7.07e-08 | 3 | 123 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | DNAH3 ABCA1 ERCC2 KALRN TRPM7 ABCA12 ABCB6 GRM1 LPAR1 ADCY8 ABCG1 CSNK1A1L LMO7 DNAH8 | 1.45e-06 | 702 | 123 | 14 | C0009402 |
| Disease | coronary artery disease (is_implicated_in) | 6.36e-05 | 100 | 123 | 5 | DOID:3393 (is_implicated_in) | |
| Disease | Colorectal Neoplasms | 1.67e-04 | 277 | 123 | 7 | C0009404 | |
| Disease | Congenital myopathy with fiber type disproportion | 2.56e-04 | 6 | 123 | 2 | cv:C0546264 | |
| Disease | syndromic X-linked intellectual disability Najm type (implicated_via_orthology) | 3.57e-04 | 7 | 123 | 2 | DOID:0060807 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.64e-04 | 153 | 123 | 5 | EFO_0004611, EFO_0020946 | |
| Disease | aortic measurement | 6.62e-04 | 251 | 123 | 6 | EFO_0020865 | |
| Disease | linoleic acid measurement | 1.12e-03 | 186 | 123 | 5 | EFO_0006807 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 1.30e-03 | 13 | 123 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 1.30e-03 | 13 | 123 | 2 | C0175709 | |
| Disease | salicylurate measurement | 1.30e-03 | 13 | 123 | 2 | EFO_0010532 | |
| Disease | X-linked centronuclear myopathy | 1.30e-03 | 13 | 123 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 1.30e-03 | 13 | 123 | 2 | C4551952 | |
| Disease | healthspan | 1.30e-03 | 13 | 123 | 2 | EFO_0009762 | |
| Disease | Skin Abnormalities | 1.30e-03 | 13 | 123 | 2 | C0037268 | |
| Disease | Congenital Structural Myopathy | 1.30e-03 | 13 | 123 | 2 | C0752282 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 1.52e-03 | 14 | 123 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 1.52e-03 | 14 | 123 | 2 | C0410207 | |
| Disease | glycerol-3-phosphate measurement | 1.75e-03 | 15 | 123 | 2 | EFO_0010488 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 1.75e-03 | 15 | 123 | 2 | C3645536 | |
| Disease | major depressive disorder (is_implicated_in) | 2.25e-03 | 17 | 123 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | Congenital Fiber Type Disproportion | 2.52e-03 | 18 | 123 | 2 | C0546264 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.33e-03 | 239 | 123 | 5 | EFO_0008317, EFO_0020945 | |
| Disease | glaucoma | 4.01e-03 | 154 | 123 | 4 | MONDO_0005041 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 4.12e-03 | 23 | 123 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 4.12e-03 | 23 | 123 | 2 | C0393682 | |
| Disease | sex interaction measurement, body mass index, age at assessment | 4.12e-03 | 23 | 123 | 2 | EFO_0004340, EFO_0008007, EFO_0008343 | |
| Disease | Uncinate Epilepsy | 4.12e-03 | 23 | 123 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 4.12e-03 | 23 | 123 | 2 | C0014556 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FSQTPLMSTYYLAWA | 321 | Q9UKU6 | |
| LMSTYYLAWAICNFT | 326 | Q9UKU6 | |
| YLQYSGVVTWVAMTT | 241 | P40145 | |
| FSTDVYIVMWDTSSY | 266 | Q5NDL2 | |
| QYFMTLTYSGEICVW | 401 | Q8NDM7 | |
| MWTVPSFTNDSYQVY | 1 | Q9NX77 | |
| VYIYDYENNSWSMSL | 116 | Q86XM0 | |
| FDTIPTYLQWMSYIS | 586 | P45844 | |
| GVTCYWVTNFIYDMV | 2026 | Q86UK0 | |
| LASDTIYQIMYSCWH | 636 | P51813 | |
| EYWYYSVFTLSMLVA | 261 | Q9HD20 | |
| DTFLYGVMTWYIEAV | 831 | O95477 | |
| IAIMTFKDYFYCWNT | 136 | Q9GZX7 | |
| FSLMTIAVGTDYWLY | 21 | O60359 | |
| YNVSYAWKMVQDTSF | 586 | Q5VU97 | |
| WFGTYYRMIQTNFID | 546 | Q9NP58 | |
| ALYYWNNEYIMSLIS | 346 | Q13362 | |
| WFREGTTMYALYITV | 421 | Q86Y34 | |
| TANLLFNSFEPYYMW | 421 | Q5JWR5 | |
| KYYATEFDWNSQMIS | 396 | Q6PIY7 | |
| QYMPWEAALSSLSYF | 691 | P15144 | |
| YIMELAFYWSLMFSQ | 191 | Q8N5B7 | |
| SWMIYTYSGLFCVTV | 111 | P12883 | |
| TSDMIPRLVYYWSFS | 746 | Q4KMQ2 | |
| FSLMTIAVGTDYWLY | 21 | Q9Y698 | |
| LYFSGVMWTLIYDTI | 236 | Q96H96 | |
| AAFWYTIVTMTTLGY | 361 | Q9NSA2 | |
| KAMVFLEYFTSNSWV | 386 | Q8WVX9 | |
| QWSSLKASDTAMYYC | 101 | A0A0J9YXX1 | |
| WSAIEIFRYSFYMLT | 251 | Q9P035 | |
| YWREICSLFYTMESL | 621 | P59045 | |
| AASMESLYDLWEFYL | 176 | Q8WVP7 | |
| LWEFVSYYDMSELLA | 2636 | Q5SZK8 | |
| SNMAPLYSDSYLVFW | 196 | Q92633 | |
| DLVSAYTLNSMFWVY | 56 | Q13901 | |
| YTLNSMFWVYLATQG | 61 | Q13901 | |
| YLSFVMLLAALSWQY | 386 | P37268 | |
| SSSSFQYMYLLKDLW | 141 | P02675 | |
| YSSAVAPNMLTDFFW | 76 | Q8NGJ0 | |
| ETYMEFLWQYKSSAD | 136 | Q9BZD4 | |
| DTVMSSISGYYEILW | 1286 | Q96JB1 | |
| AVSYAWMFAYTRLQL | 821 | O94915 | |
| CFVTWADKFQMYVTY | 1361 | O60229 | |
| ICHIFTFYSWMSYDV | 6 | Q8WWI1 | |
| TFYSWMSYDVLFQRT | 11 | Q8WWI1 | |
| SYQYMESTVASWYEQ | 541 | P18074 | |
| RTLNHQYDYTFDWTM | 286 | Q8N752 | |
| TMYYFLTNLSFIDMW | 56 | Q8NGN5 | |
| YAWMLCVFTVIVAYS | 611 | O94886 | |
| ILFAHSSWYTYAAML | 241 | Q6P4A8 | |
| QWSSLKASDTAMYYC | 101 | A0A0C4DH38 | |
| FYFNPATMTSEWTTY | 566 | Q16827 | |
| ATMTSEWTTYYEIAA | 571 | Q16827 | |
| NYSLTDFWAYMVISK | 131 | Q9UP65 | |
| NIFWSSLMYLSYLVL | 231 | Q9H5J4 | |
| TMWIERTTYTTAYTF | 1481 | Q9H7D0 | |
| LANIEPMYQYSLTWF | 3311 | Q8TD57 | |
| FWNSSKYNMVSYLLR | 341 | Q53EU6 | |
| QTYYLLDQWVFGTVM | 91 | P51685 | |
| IGYFIMLAVMSYNTW | 106 | O15432 | |
| IMSYRNADYSYSVWK | 1056 | P01031 | |
| IQKSWTATTYMEYET | 181 | P53634 | |
| IAVSTDYWLYMEEGT | 26 | P62955 | |
| IVYEFLMSGWLSTYT | 76 | Q9BW60 | |
| YLATAVWMSFAQAAV | 321 | Q9NS66 | |
| SSDWVTQYRMLYSDT | 106 | Q9UHC6 | |
| DCLMYDTTWYSSVDQ | 66 | P56749 | |
| YIAFTMYTTCIIWLA | 786 | Q13255 | |
| MTSTIAWNLVASYYE | 301 | P54803 | |
| TLVMSCVWFTVSYTY | 381 | Q9Y267 | |
| VIWFSNSVAYYGLAM | 346 | A6NK97 | |
| FISSWYYAIVAMVIA | 696 | Q9UHW9 | |
| FAWFTSAVVYQGLVM | 356 | O75751 | |
| TDNSFLYLGWYMVMS | 4786 | P21817 | |
| DNSFLYLAWYMTMSV | 4716 | Q92736 | |
| SFALATQYMSVWELF | 166 | O95992 | |
| YFLSSMSFLEIWYVS | 61 | Q6IFH4 | |
| YTSLCQYFSEEDMVW | 3011 | P98161 | |
| YSLYMFTTTQWGSLT | 406 | P03905 | |
| LACTDTWVYEYMVFV | 186 | Q8N349 | |
| TWVYEYMVFVSTSLF | 191 | Q8N349 | |
| IVSRMVFYFHYSSWD | 401 | Q6ZUA9 | |
| MDLLYWQFTIYTITF | 16 | Q9HBX3 | |
| SWISELYQNTVIYML | 251 | Q9NYV9 | |
| TSFMVGLYYNTIISW | 121 | Q695T7 | |
| WYSLMSSAQPDTSYV | 231 | Q9BUR4 | |
| FTTMDLYKSSLCWYD | 391 | O43897 | |
| FYRYDIDTNTWMLLS | 361 | Q9UL63 | |
| VSWIFSEQMLVYYIN | 726 | Q9H3E2 | |
| MYSFNTLRLYLWETI | 1 | P23415 | |
| RTLNHQYDYTFDWTM | 286 | P48729 | |
| TWSSYYFDLQLLVFM | 356 | P46977 | |
| YFLSSMSFLEIWYVS | 61 | Q8NGW1 | |
| YQWVYTASMVFMLVF | 851 | Q96J65 | |
| QSWYMQSFLELLEYE | 81 | Q15120 | |
| KQMSWFYYQYLLVTA | 11 | Q969W0 | |
| FVSSWYYALVAMLIA | 631 | Q9UP95 | |
| ASLYIMMTLTNWYRY | 396 | Q9NRX5 | |
| LISMGFNVALWYTKY | 111 | Q5VW32 | |
| YTMEWYELFQLGNCT | 131 | O75503 | |
| WSMTSDIYFDNFIIC | 416 | O14967 | |
| VYYVAVMSDWDTSCL | 101 | Q96LM1 | |
| QSEYLMLWLVLDYSA | 196 | Q16281 | |
| SYIMNYIMYIFWALS | 206 | P51790 | |
| YVVVWANIYSTSQMF | 111 | Q5VZI3 | |
| GYQDSSSFYVVMWKQ | 801 | P35443 | |
| SSFYVVMWKQTEQTY | 806 | P35443 | |
| WTTAASDMKFEYLLY | 256 | O43829 | |
| QEIYTSFYTMKWFFQ | 256 | Q92738 | |
| YVALAWTSSALMYFI | 231 | O95070 | |
| YATFWSLTMYDLAVP | 881 | Q8NI27 | |
| WMQSYSTSFLTDSYL | 331 | Q9UJ98 | |
| MVFSLALGWTNMLYY | 541 | Q8NER1 | |
| SFLYLAWYTTMSVLG | 4621 | Q15413 | |
| MAEQTYSWAYSLVDS | 1 | Q8TCT6 | |
| SLYVMVTLTNWFSYE | 436 | A6NH21 | |
| YWDVMLENYSNLVSL | 31 | Q9NQX6 | |
| EWMYSSAAEQLLAEY | 976 | Q8IZH2 | |
| SNWSFLYVTVSLYTM | 101 | Q9NQQ7 | |
| IYWLLLMDNYAASFS | 521 | P48067 | |
| SASYIWLMEQDTFVA | 376 | Q86WI1 | |
| KNTSSWVLYNMASFY | 221 | Q96AE7 | |
| AVLAMSSRSWLSYSY | 711 | Q15393 | |
| AFWIISMTASTYYGN | 31 | Q96HH6 | |
| YRDVMWENYSNFISL | 31 | Q9HCL3 | |
| TASYDTNVIMWDPYT | 256 | Q9NYS7 | |
| AQVWMITRYDLYHTF | 151 | Q9BVK8 | |
| YNTIMAWALYYLISS | 176 | P31645 | |
| TRDAMESDLLWTYYL | 181 | A6NGA9 | |
| YMLYLTAESKWSFSL | 276 | Q9H3S5 | |
| LLIFYNADDMSWLYT | 426 | Q9BVG3 | |
| TLTSLYALYNNWEHM | 186 | O14925 | |
| EIMLAFSHWTYEYTR | 1746 | Q96QT4 | |
| LMSEEHTAVYTAWYL | 931 | Q562E7 | |
| VDASSMWLYRRYYSN | 66 | Q8NHX9 | |
| QYFQDRTSWEVFSYM | 96 | Q96S06 | |
| LEYFSVYGTALSMWV | 66 | A6NI61 | |
| IMVYTNSSNTLYWEL | 96 | Q96L15 |